Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays

Influenza and other Respiratory Viruses

Volumn 6, Issue 2, 2012, Pages 127-135

  Cwach, Kevin T ^a   Sandbulte, Heather R ^a   Klonoski, Joshua M ^a   Huber, Victor C ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Assay; Influenza; Innate immunity; Murine; Serology; Virus

Indexed keywords

ALPHA 2 MACROGLOBULIN; INFLUENZA VACCINE; RECEPTOR DESTROYING ENZYME; UNCLASSIFIED DRUG; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS INTERFERENCE; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HOT TEMPERATURE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MACROPHAGES; MICE; NEURAMINIDASE; NEUTRALIZATION TESTS; PHAGOCYTOSIS; SERUM; SPECIMEN HANDLING;

EID: 84857039318     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00283.x     Document Type: Article

References (44)

1. Kilbourne ED, Butler WT, Rossen RD. From the National Institutes of Health. J Infect Dis 1973; 127:220-236.
2. Eichelberger M, Golding H, Hess M et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008; 26:4299-4303.
3. Stephenson I, Das RG, Wood JM, Katz JM. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 2007; 25:4056-4063.
4. WHO. WHO Manual on Animal Influenza Diagnosis and Surveillancein Webster RG, Cox N, Stohr K (eds) Geneva, Switzerland: World Health Organization, 2002; 1-135.
5. Matrosovich M, Gao P, Kawaoka Y. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host. J Virol 1998; 72:6373-6380.
6. Anders EM, Hartley CA, Jackson DC. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci USA 1990; 87:4485-4489.
7. Pritchett TJ, Paulson JC. Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. J Biol Chem 1989; 264:9850-9858.
8. Krizanova O, Rathova V. Serum inhibitors of myxoviruses. Curr Top Microbiol Immunol 1969; 47:125-151.
9. Subbarao EK, Kawaoka Y, Ryan-Poirier K, Clements ML, Murphy BR. Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors. J Clin Microbiol 1992; 30:996-999.
10. Hartley CA, Jackson DC, Anders EM. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin. J Virol 1992; 66:4358-4363.
11. Smith W, Westwood JC. Influenza virus haemagglutination; the mechanism of the Francis phenomenon. Br J Exp Pathol 1950; 31:725-738.
12. Konno J. Studies on several inhibitors against influenza viruses. 2. beta-Inhibitor, its biological and physicochemical properties with particular emphasis on the differences from alpha-inhibitor, immune serum and properdin. Tohoku J Exp Med 1958; 67:391-405.
13. Ryan-Poirier KA, Kawaoka Y. Alpha 2-macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum. Virology 1993; 193:974-976.
14. Cohen A, Belyavin G. Hemagglutination inhibition of Asian influenza viruses: a new pattern of response. Virology 1959; 7:59-74.
15. Francis T. Dissociation of hemagglutinating and antibody-measuring capacities of influenza virus. J Exp Med 1947; 85:1-7.
16. Hartshorn KL, White MR, Shepherd V, Reid K et al. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 1997; 273:L1156-L1166.
17. Huber VC, Thomas PG, McCullers JA. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. Vaccine 2009; 27:1192-1200.
18. Huber VC, McKeon RM, Brackin MN, Miller LA et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 2006; 13:981-990.
19. Halasa N, Englund JA, Nachman S, Weinberg GA et al. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Vaccine 2011; 29:4110-4115.
20. Huber VC, McCullers JA. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. J Infect Dis 2006; 193:677-684.
21. Huber VC, Kleimeyer LH, McCullers JA. Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine 2008; 26:5381-5388.
22. Huber VC, Peltola V, Iverson AR, McCullers JA. Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications. J Virol 2010; 84:4105-4108.
23. Widjaja L, Ilyushina N, Webster RG, Webby RJ. Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology 2006; 350:137-145.
24. Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 2001; 166:7381-7388.
25. Smith DJ, Lapedes AS, De Jong JC, Bestebroer TM et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004; 305:371-376.
26. Kang S, Yang IS, Lee JY, Park Y et al. Epidemiologic study of human influenza virus infection in South Korea from 1999 to 2007: origin and evolution of A/Fujian/411/2002-like strains. J Clin Microbiol 2010; 48:2177-2185.
27. Frank AL, Puck J, Hughes BJ, Cate TR. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol 1980; 12:426-432.
28. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37:937-943.
29. Caceres LC, Bonacci GR, Sanchez MC, Chiabrando GA. Activated alpha(2) macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-kappaB activation in macrophage-derived cell lines. J Cell Biochem 2010; 111:607-617.
30. Brans LM, Hertzberger E, Binkhorst JL. Studies on the elimination of non-specific inhibitors in sera against influenza viruses with the aid of filtrates of Vibrio cholerae. Antonie Van Leeuwenhoek 1953; 19:309-323.
31. Shortridge KF, Lansdell A. Serum inhibitors of A 2 -Hong Kong influenza virus haemagglutination. Microbios 1972; 6:213-219.
32. Tokunaga H, Ushirogawa H, Ohuchi M. The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin. Virol J 2011; 8:50.
33. Chen CH, Zhang XQ, Lo CW, Liu PF et al. The essentiality of alpha-2-macroglobulin in human salivary innate immunity against new H1N1 swine origin influenza A virus. Proteomics 2010; 10:2396-2401.
34. Hovi T, Mosher D, Vaheri A. Cultured human monocytes synthesize and secrete alpha2-macroglobulin. J Exp Med 1977; 145:1580-1589.
35. White R, Janoff A, Godfrey HP. Secretion of Alpha-2-macroglobulin by human alveolar macrophages. Lung 1980; 158:9-14.
36. Armstrong PB. Proteases and protease inhibitors: a balance of activities in host-pathogen interaction. Immunobiology 2006; 211:263-281.
37. Geiger T, Andus T, Klapproth J, Hirano T et al. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18:717-721.
38. Gresser I, Delers F, Tran QN, Marion S et al. Tumor necrosis factor induces acute phase proteins in rats. J Biol Regul Homeost Agents 1987; 1:173-176.
39. Chu CT, Howard GC, Misra UK, Pizzo SV. Alpha 2-macroglobulin: a sensor for proteolysis. Ann NY Acad Sci 1994; 737:291-307.
40. Misra UK, Chu CT, Gawdi G, Pizzo SV. Evidence for a second alpha 2-macroglobulin receptor. J Biol Chem 1994; 269:12541-12547.
41. Hofer F, Gruenberger M, Kowalski H, Machat H et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci USA 1994; 91:1839-1842.
42. Suzuki Y, Ito T, Suzuki T, Holland RE Jr et al. Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 2000; 74:11825-11831.
43. Ryan-Poirier KA, Kawaoka Y. Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J Virol 1991; 65:389-395.
44. Kurdowska A, Alden SM, Noble JM, Stevens MD, Carr FK. Involvement of alpha-2-macroglobulin receptor in clearance of interleukin 8-alpha-2-macroglobulin complexes by human alveolar macrophages. Cytokine 2000; 12:1046-1053.